Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Core Laboratories NV Issues Q2 2013 Guidance Above Analysts' Estimates; Raises FY 2013 Guidance


Wednesday, 17 Apr 2013 06:00pm EDT 

Core Laboratories NV announced that second quarter of 2013, it expects revenue of approximately $264,000,000 to $269,000,000, after taking into account seasonal effects, and EPS in the $1.29 to $1.36 range. For fiscal 2013, it expects revenue to range between $1,060,000,000 and $1,075,000,000 and EPS to a range between $5.06 to $5.26. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $261 million and EPS of $1.26 for the second quarter of 2013; revenues of $1.058 billion and EPS of $5.12 for fiscal 2013. 

Company Quote

162.46
0.37 +0.23%
4:04pm EDT